Pereira M, Williams VL, Hallanger Johnson J, Valderrabano P. Thyroid cancer incidence trends in the United States: association with changes in professional guideline recommendations. Thyroid. 2020;30:1132–40.

Article  PubMed  Google Scholar 

Cui Y, Mubarik S, Li R, Nawsherwan YuC. Trend dynamics of thyroid cancer incidence among China and the U.S. adult population from 1990 to 2017: a joinpoint and age-period-cohort analysis. BMC Public Health. 2021;21:624.

Article  PubMed  PubMed Central  Google Scholar 

Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1–133.

Article  PubMed  PubMed Central  Google Scholar 

NCCN. NCCN clinical practice guidelines in oncology- Thyroid carcinoma (version3. 2021). [EB/OL]. Fort Washington: NCCN 2021[2021-10-15]. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1470. Accessed 15 Oct 2021

Filetti S, Durante C, Hartl D, Leboulleux S, Locati LD, Newbold K, et al. Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up†. Ann Oncol. 2019;30:1856–83.

Article  CAS  PubMed  Google Scholar 

Papaleontiou M, Evron JM, Esfandiari NH, Reyes-Gastelum D, Ward KC, Hamilton AS, et al. Patient report of recurrent and persistent thyroid cancer. Thyroid. 2020;30:1297–305.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zahedi A, Bondaz L, Rajaraman M, Leslie WD, Jefford C, Young JE, et al. Risk for thyroid cancer recurrence is higher in men than in women independent of disease stage at presentation. Thyroid. 2020;30:871–7.

Article  PubMed  Google Scholar 

Shaha AR. Recurrent differentiated thyroid cancer. Endocr Pract. 2012;18:600–3.

Article  PubMed  Google Scholar 

Hung ML, Wu JX, Li N, Livhits MJ, Yeh MW. Association of radioactive iodine administration after reoperation with outcomes among patients with recurrent or persistent papillary thyroid cancer. JAMA Surg. 2018;153:1098–104.

Article  PubMed  PubMed Central  Google Scholar 

Yim JH, Kim WB, Kim EY, Kim WG, Kim TY, Ryu JS, et al. Adjuvant radioactive therapy after reoperation for locoregionally recurrent papillary thyroid cancer in patients who initially underwent total thyroidectomy and high-dose remnant ablation. J Clin Endocrinol Metab. 2011;96:3695–700.

Article  CAS  PubMed  Google Scholar 

Bouvet C, Barres B, Kwiatkowski F, Batisse-Lignier M, Chafai El Alaoui M, Kauffmann P, et al. Re-treatment with adjuvant radioactive iodine does not improve recurrence-free survival of patients with differentiated thyroid cancer. Front Endocrinol (Lausanne). 2019;10:671.

Article  PubMed  PubMed Central  Google Scholar 

Saito Y, Matsuzu K, Sugino K, Takami H, Kitagawa W, Nagahama M, et al. The impact of completion thyroidectomy followed by radioactive iodine ablation for patients with lymph node recurrence of papillary thyroid carcinoma. Surgery. 2019;166:342–8.

Article  PubMed  Google Scholar 

Rosario PW, Mourão GF, Calsolari MR. Role of adjuvant therapy with radioactive iodine in patients with elevated serum thyroglobulin after neck reoperation due to recurrent papillary thyroid cancer: a monoinstitutional comparative study. Endocrine. 2020;68:144–50.

Article  Google Scholar 

Piccardo A, Puntoni M, Bottoni G, Treglia G, Foppiani L, Bertoli M, et al. Differentiated thyroid cancer lymph-node relapse. Role of adjuvant radioactive iodine therapy after lymphadenectomy. Eur J Nucl Med Mol Imaging. 2017;44:926–34.

Article  CAS  PubMed  Google Scholar 

Kalaitzidou S, Papadakis G, Sapera A, Tampouratzi D, Drosou A, Triantafillou E, et al. Outcomes of surgery and radioiodine treatment for neck recurrence in papillary thyroid cancer. J BUON. 2020;25:383–8.

PubMed  Google Scholar 

Lamartina L, Borget I, Mirghani H, Al Ghuzlan A, Berdelou A, Bidault F, et al. Surgery for neck recurrence of differentiated thyroid cancer: outcomes and risk factors. J Clin Endocrinol Metab. 2017;102:1020–31.

PubMed  Google Scholar 

Nam SH, Roh JL, Gong G, Cho KJ, Choi SH, Nam SY, et al. Nodal factors predictive of recurrence after thyroidectomy and neck dissection for papillary thyroid carcinoma. Thyroid. 2018;28:88–95.

Article  PubMed  Google Scholar 

Veronese N, Luchini C, Nottegar A, Kaneko T, Sergi G, Manzato E, et al. Prognostic impact of extra-nodal extension in thyroid cancer: a meta-analysis. J Surg Oncol. 2015;112:828–33.

Article  PubMed  Google Scholar 

Lango M, Flieder D, Arrangoiz R, Veloski C, Yu JQ, Li T, et al. Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression. Thyroid. 2013;23:1099–105.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ito Y, Hirokawa M, Jikuzono T, Higashiyama T, Takamura Y, Miya A, et al. Extranodal tumor extension to adjacent organs predicts a worse cause-specific survival in patients with papillary thyroid carcinoma. World J Surg. 2007;31:1194–201.

Article  PubMed  Google Scholar 

Wu MH, Shen WT, Gosnell J, Duh QY. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer. Head Neck. 2015;37:1336–43.

Article  PubMed  Google Scholar